ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 1366 - 1380 of 5504 products
Innovent Reports Positive Data from Phase III Trial of Tyvyt for NSCLC
$5.00
Available
NeuPharma Starts Phase II Trial of Novel Treatment for Glioblastoma Multiforme
$5.00
Available
ABM Therapeutics Completes $20 Million Round for Neural Cancer Drugs
$5.00
Available
CStone Reports Positive Results from Phase III Lung Cancer Trial of Immunotherapy
$5.00
Available
Biogen Enters $2 Billion Deal to Co-Develop Parkinson's Candidate in US and China
$5.00
Available
Lepu Biotech Closes $186 Million B Round for Cancer Immunotherapies
$5.00
Available
VistaGen Receives $5 Million Upfront Fee from EverInsight for SAD Therapy
$5.00
Available
Fosun Doses 72 Subjects in China Trial of mRNA COVID-19 Vaccine
$5.00
Available
Zai Lab Granted China Priority Review for GIST Treatment
$5.00
Available
Innovent Starts Phase I Trial of CD47/PD-L1 Bispecific for Solid Tumor Cancers
$5.00
Available
Sherpa Healthcare Closes $200 Million Life Science Venture/Growth Fund
$5.00
Available
Simcere Signs $170 Million Deal for Myelopreservation Therapy
$5.00
Available
Qilu Pharma In-licenses Bladder Cancer Drug in $35 Million Deal
$5.00
Available
Ascletis Approved to Market Dual All-oral HCV Treatment
$5.00
Available
Harbour BioMed and Viva Bio Partner to Offer Incubation Services
$5.00
Available